Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S (2016) Implementation of the European multicentre database of healthy controls for [123 I] FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging. 43(7):1315–1322
Article
CAS
PubMed
Google Scholar
Barnden LR, Dickson J, Hutton BF (2006) Detection and validation of the body edge in low count emission tomography images. Comput Methods Programs Biomed. 84(2-3):153–161
Article
PubMed
Google Scholar
Benítez-Rivero S, Marín-Oyaga VA, García-Solís D, Huertas-Fernández I, García-Gómez FJ, Jesús S, Cáceres MT, Carrillo F, Ortiz AM, Carballo M, Mir P (2013) Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson’s disease. J Neurol Neurosurg Psychiatry. 84(2):122–129
Article
PubMed
Google Scholar
Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA (1997a) [123I] FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse. 27(3):183–190
Article
CAS
PubMed
Google Scholar
Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, Van Royen EA (1998) Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson’s disease. J Nucl Med 39(11):1879–1884
CAS
PubMed
Google Scholar
Booij J, Speelman JD, Horstink MW, Wolters EC (2001) The clinical benefit of imaging striatal dopamine transporters with [123I] FP-CIT SPET in differentiating patients with presynaptic Parkinsonism from those with other forms of Parkinsonism. Eur J Nucl Med. 28(3):266–272
Article
CAS
PubMed
Google Scholar
Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, Van Royen EA (1997b) [123I] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 62(2):133–140
Article
CAS
PubMed
PubMed Central
Google Scholar
Booth TC, Nathan M, Waldman AD, Quigley AM, Schapira AH, Buscombe J (2015) The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2. Am J Neuroradiol 36(2):236–244
Article
CAS
PubMed
PubMed Central
Google Scholar
Buchert R, Hutton C, Lange C, Hoppe P, Makowski M, Bamousa T, Platsch G, Brenner W, Declerck J (2016b) Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT. Nucl Med Commun 37(5):509–518
Article
CAS
PubMed
Google Scholar
Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, Asenbaum S, Booij J, Kapucu LÖ, Svarer C, Koulibaly PM (2016a) Reduction in camera-specific variability in [123 I] FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging. 43(7):1323–1336
Article
CAS
PubMed
Google Scholar
Catafau AM, Tolosa E (2004) Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 19(10):1175–1182
Article
PubMed
Google Scholar
Cohen P, West SG, Aiken LS (2014) Applied multiple regression/correlation analysis for the behavioral sciences. Psychology Press, Taylor and Francis Group, New York
Contrafatto D, Mostile G, Nicoletti A, Dibilio V, Raciti L, Lanzafame S, Luca A, Distefano A, Zappia M (2012) [123I] FP-CIT-SPECT asymmetry index to differentiate Parkinson’s disease from vascular parkinsonism. Acta Neurol Scand 126(1):12–16
Article
CAS
PubMed
Google Scholar
Costa A, la Fougère C, Pogarell O, Möller HJ, Riedel M, Ettinger U (2013) Impulsivity is related to striatal dopamine transporter availability in healthy males. Psychiatry Res 211(3):251–256
Article
CAS
PubMed
Google Scholar
Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu ÖL, Någren K, Nobili F, Walker Z, Van Laere K (2010) EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 37(2):443–450
Article
CAS
PubMed
Google Scholar
Dickson JC, Tossici-Bolt L, Sera T, De Nijs R, Booij J, Bagnara MC, Seese A, Koulibaly PM, Akdemir UO, Jonsson C, Koole M (2012) Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123 I-FP-CIT SPECT database. Eur J Nucl Med Mol Imaging. 39(1):188–197
Article
PubMed
Google Scholar
Djang DS, Janssen MJ, Bohnen N, Booij J, Henderson TA, Herholz K, Minoshima S, Rowe CC, Sabri O, Seibyl J, Van Berckel BN (2012) SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 53(1):154–163
Article
CAS
PubMed
Google Scholar
El Fakhri G, Habert MO, Maksud P, Kas A, Malek Z, Kijewski MF, Lacomblez L (2006) Quantitative simultaneous 99m Tc-ECD/123 I-FP-CIT SPECT in Parkinson’s disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 33(1):87–92
Article
PubMed
Google Scholar
Eusebio A, Azulay JP, Ceccaldi M, Girard N, Mundler O, Guedj E (2012) Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects. Eur J Nucl Med Mol Imaging. 39(11):1778–1783
Article
CAS
PubMed
Google Scholar
Haapaniemi TH, Ahonen A, Torniainen P, Sotaniemi KA, Myllylä VV (2001) [123I] β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov Disord 16(1):124–130
Article
CAS
PubMed
Google Scholar
Kaasinen V, Joutsa J, Noponen T, Johansson J, Seppänen M (2015) Effects of aging and gender on striatal and extrastriatal [123I] FP-CIT binding in Parkinson’s disease. Neurobiol Aging. 36(4):1757–1763
Article
CAS
PubMed
Google Scholar
Koch W, Radau PE, Münzing W, Tatsch K (2006) Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom. Eur J Nucl Med Mol Imaging. 33(4):495–502
Article
PubMed
Google Scholar
Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA (2000) Effect of age and gender on dopamine transporter imaging with [123 I] FP-CIT SPET in healthy volunteers. Eur J Nucl Med. 27(7):867–869
Article
CAS
PubMed
Google Scholar
Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, Inui Y, Taki Y, Shimomura H, Nagayama H, Tateno A (2018) Japanese multicenter database of healthy controls for [123 I] FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 45(8):1405–1416
Article
CAS
PubMed
PubMed Central
Google Scholar
Mozley LH, Gur RC, Mozley PD, Gur RE (2001) Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry. 158(9):1492–1499
Article
CAS
PubMed
Google Scholar
Mozley PD, Kim HJ, Gur RC, Tatsch K, Muenz LR, McElgin WT, Kung MP, Mu M, Myers AM, Kung HF (1996) Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med. 37(12):1965–1970
CAS
PubMed
Google Scholar
Neumeyer JL, Campbell A, Wang S, Gao Y, Milius RA, Kula NS, Baldessarini RJ, Zea-Ponce Y, Baldwin RM, Innis RB (1994) N-Omega-fluoroalkyl analogs of (1R)-2β-carbomethoxy-3β-(4-iodophenyl) tropane (β-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 37(11):1558–1561
Article
CAS
PubMed
Google Scholar
Nicastro N, Burkhard PR, Garibotto V (2018) Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: a prospective study. J Neurol Sci 385:17–21
Article
PubMed
Google Scholar
Nicastro N, Garibotto V, Allali G, Assal F, Burkhard PR (2017) Added value of combined semi-quantitative and visual [123I] FP-CIT SPECT analyses for the diagnosis of dementia with Lewy bodies. Clin Nucl Med 42(2):96–102
Article
Google Scholar
Nicastro N, Garibotto V, Poncet A, Badoud S, Burkhard PR (2016) Establishing on-site reference values for 123 I-FP-CIT SPECT (DaTscan®) using a cohort of individuals with non-degenerative conditions. Mol Imaging Biol 18(2):302–312
Article
CAS
PubMed
Google Scholar
Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, Ell P, Kapucu Ö, Kemp P, Varer C, Morbelli S (2013) Automatic semi-quantification of [123 I] FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 40(4):565–573
Article
PubMed
Google Scholar
O’sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ (2008) Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord. 23(1):101–106
Article
PubMed
Google Scholar
Pirker W, Asenbaum S, Hauk M, Kandlhofer S (2000) Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med. 41(1):36–44
CAS
PubMed
Google Scholar
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 30(12):1591–1601
Article
PubMed
Google Scholar
Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. 86(6):566–576
Article
PubMed
Google Scholar
Ryding E, Lindström M, Brådvik B, Grabowski M, Bosson P, Träskman-Bendz L, Rosén I (2004) A new model for separation between brain dopamine and serotonin transporters in 123I-β-CIT SPECT measurements: normal values and sex and age dependence. Eur J Nucl Med Mol Imaging. 31(8):1114–1118
Article
CAS
PubMed
Google Scholar
Shin HY, Kang SY, Yang JH, Kim HS, Lee MS, Sohn YH (2007) Use of the putamen/caudate volume ratio for early differentiation between parkinsonian variant of multiple system atrophy and Parkinson disease. J Clin Neurol 3(2):79–81
Article
PubMed
PubMed Central
Google Scholar
Sixel-Döring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C (2011) The role of 123 I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258(12):2147–2154
Article
PubMed
Google Scholar
Söderlund TA, Dickson JC, Prvulovich E, Ben-Haim S, Kemp P, Booij J, Nobili F, Thomsen G, Sabri O, Koulibaly PM, Akdemir OU (2013) Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane SPECT studies. J Nucl Med. 54(5):714–722
Article
PubMed
CAS
Google Scholar
Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB (2001) Sex differences in [123I] β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse. 41(4):275–284
Article
CAS
PubMed
Google Scholar
Tatsch K, Poepperl G (2013) Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update. J Nucl Med 54(8):1331–1338
Article
CAS
PubMed
Google Scholar
Thobois S, Prange S, Scheiber C, Broussolle E (2019) What a neurologist should know about PET and SPECT functional imaging for parkinsonism: a practical perspective. Parkinsonism Relat Disord 59:93–100
Article
PubMed
Google Scholar
Tondeur MC, Hambye AS, Dethy S, Ham HR (2010) Interobserver reproducibility of the interpretation of I-123 FP-CIT single-photon emission computed tomography. Nuclear Med Commun 31(8):717–725
Article
Google Scholar
Tossici-Bolt L, Dickson JC, Sera T, De Nijs R, Bagnara MC, Jonsson C, Scheepers E, Zito F, Seese A, Koulibaly PM, Kapucu OL (2011) Calibration of gamma camera systems for a multicentre European 123 I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 38(8):1529–1540
Article
PubMed
Google Scholar
van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB, Innis RB (1995) Age-related decline in striatal dopamine transporter binding with iodine-123-β-CITSPECT. J Nucl Med. 36(7):1175–1181
PubMed
Google Scholar
van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, Innis RB (2002) Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry. 10(1):36–43
Article
PubMed
Google Scholar
Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Knudsen GM, Koulibaly PM, Nobili F (2013) European multicentre database of healthy controls for [123 I] FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 40(2):213–227
Article
CAS
PubMed
Google Scholar
Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, Schulz K (2007) Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage. 34(3):1182–1190
Article
PubMed
Google Scholar
Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG, Katona CL (2002) Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 73(2):134–140
Article
CAS
PubMed
PubMed Central
Google Scholar